SynthesisFrontiers in immunology2026
Global research landscape and emerging trends of tertiary lymphoid structures in autoimmune diseases: a bibliometric analysis.
Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tertiary lymphoid structures (TLSs) are increasingly regarded as important local immune niches in chronic inflammation and autoimmunity. However, a focused bibliometric overview of TLS research in autoimmune diseases is still lacking. Methods: Publications on TLSs in autoimmune diseases published between 2006 and 2025 were retrieved from the Web of Science Core Collection and Scopus databases. After screening and deduplication, the eligible records were analyzed using Bibliometrix/Biblioshiny, VOSviewer, and CiteSpace to assess publication trends, collaboration patterns, co-citation networks, keyword clustering, and thematic evolution. Results: A total of 479 publications were included. Annual output showed an overall upward trend, indicating sustained interest in this field. The United States occupied a central position in the international collaboration network, while several European countries also made important contributions. Rheumatoid arthritis, Sjögren's syndrome, systemic lupus erythematosus/lupus nephritis, and myasthenia gravis emerged as the major disease contexts of TLS research. The field evolved from early attention to lymphoid neogenesis, chemokine-mediated tissue organization, and ectopic germinal center-like responses toward local B-cell hyperactivity, disease-specific immune microenvironments, and clinical heterogeneity. Recent frontiers include T follicular helper/peripheral helper T-cell axes, stromal remodeling, fibroblast-associated immune organization, disease subsets, and single-cell/spatial omics approaches. Conclusion: TLS research in autoimmune diseases has evolved from structural recognition toward functional interpretation, disease stratification, and translational exploration. Further studies integrating mechanistic investigation with clinical stratification are needed to clarify the translational relevance of TLSs in precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.